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ABSTRACT
While the build-up of oxidized proteins within cells is believed
to be toxic, there is currently no evidence linking protein
carbonylation and cell death. In the present study, we show
that incubation of nPC12 (neuron-like PC12) cells with 50 mM
DEM (diethyl maleate) leads to a partial and transient
depletion of glutathione (GSH). Concomitant with GSH
disappearance there is increased accumulation of PCOs
(protein carbonyls) and cell death (both by necrosis and
apoptosis). Immunocytochemical studies also revealed a
temporal/spatial relationship between carbonylation and
cellular apoptosis. In addition, the extent of all three, PCO
accumulation, protein aggregation and cell death, augments
if oxidized proteins are not removed by proteasomal
degradation. Furthermore, the effectiveness of the carbonyl
scavengers hydralazine, histidine hydrazide and methoxy-
lamine at preventing cell death identifies PCOs as the toxic
species. Experiments using well-characterized apoptosis
inhibitors place protein carbonylation downstream
of the mitochondrial transition pore opening and up-
stream of caspase activation. While the study focused mostly
on nPC12 cells, experiments in primary neuronal cultures
yieldedthesame results. The findingsarealso not restricted to
DEM-induced cell death, since a similar relationship between
carbonylation and apoptosis was found in staurosporine- and
buthionine sulfoximine-treated nPC12 cells. In sum, the above
results show for the first time a causal relationship between
carbonylation, protein aggregation and apoptosis of neurons
undergoing oxidative damage. To the best of our knowledge,
this is the first study to place direct (oxidative) protein
carbonylation within the apoptotic pathway.
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INTRODUCTION
Many neurological disorders are characterized by severe and/
or prolonged oxidative stress conditions, which play a
significant pathophysiological role (Reynolds et al., 2007;
Jomova et al., 2010). The major outcome of oxidative stress is
the irreversible damage of cell macromolecules by ROS
(reactive oxygen species). Proteins are the major target for
oxidants as a result of their abundance and their elevated
reaction rate constants (Davies, 2005). Although the
polypeptide backbone and the side chains of most amino
acids are susceptible to oxidation, the non-enzymatic
introduction of aldehyde or ketone functional groups to
specific amino acid residues (also known as carbonylation)
constitutes the most common oxidative alteration of proteins
(Bizzozero, 2009). Accumulation of PCOs (protein carbonyls)
does not only occur, but has also been implicated, in the
aetiology and/or progression of several CNS (central nervous
system) disorders, including Alzheimer’s disease (Aksenov
et al., 2001), Parkinson’s disease (Floor and Wetzel, 1998),
amyotrophic lateral sclerosis (Ferrante et al., 1997) and
multiple sclerosis (Bizzozero et al., 2005).
Carbonylation is believed to have deleterious effects on
both protein function and cell viability. However, while there
is ample experimental evidence demonstrating that the
presence of carbonyl groups leads to changes in protein
structure and function (Fucci et al., 1983; Starke et al., 1987;
Dalle-Donne et al., 2001), a direct relationship between
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asnneuro.org / Volume 4 (3) / art:e00084 161protein carbonylation and cell death has not been conclu-
sively established. The major problem lies in the difficulty of
differentiatingtheeffect(s)ofcarbonylationfrom thatofother
protein modifications that occur simultaneously under oxida-
tiving stress conditions (e.g. oxidation of cysteine thiols and
nitration of tyrosine residues). Nonetheless, a number of
studies have recently surfaced suggesting a link between
increased protein carbonylation and loss of cell viability. For
instance, carbonylation of critical glycolytic enzymes in
etopside-treated HL60 cells seems to decrease glucose
utilization and cause cell death (England et al., 2004), while
oxidation of several chaperones has been associated with
apoptosis of irradiated HL60 human leukaemia cells (Magi
et al., 2004). In addition, carbonylation may lead to the
formation of large, protease-resistant protein aggregates,
which are considered highly cytotoxic (Nystro ¨m, 2005;
Maisonneuve et al., 2008).
Because of the potential cellular toxicity that results from
the accumulation of carbonylated proteins, their intracellular
levels are normally maintained at very low levels by
proteolytic removal. Among the various cellular proteases,
the 20S proteasome, via its chymotrypsin-like activity and in
an ATP-independent manner, has been shown to be
responsible for digesting oxidized proteins (Shringarpure
et al., 2003; Divald and Powell, 2006). Indeed, failure of this
proteolytic system, as happens in many neurodegenerative
disorders, results in the build up of oxidized proteins that
likely contribute to cellular dysfunction and tissue damage
(Rinaudo and Piccinini, 2007).
In recent years, our laboratory has been investigating the
mechanism of protein carbonylation and the metabolic/
cellular impact of increased protein oxidation in inflam-
matory demyelinating disorders. We have found that PCOs
accumulate in the CNS of patients with multiple sclerosis
(Bizzozero et al., 2005) and of animals with EAE (experi-
mental autoimmune encephalomyelitis; Smerjac and
Bizzozero, 2008; Zheng and Bizzozero, 2010b). Recent
immunohistochemical experiments in the spinal cord of
EAE mice have demonstrated a positive correlation between
carbonylation levels and neuronal/oligodendrocyte apopto-
sis (Dasgupta and Bizzozero, 2011). Based on these findings,
we set up to investigate whether a relationship, causal or
otherwise, exists between protein carbonylation and
neuronal cell death in vitro. To this end, the concentration
of GSH in NGF (nerve growth factor)-treated PC12 cells
or primary neurons was reduced to levels similar to those
found in the spinal cord of EAE animals. Under these oxi-
dative stress conditions, immunocytochemical studies
revealed for the first time a close temporal/spatial rela-
tionship between carbonylation and apoptosis. Experi-
ments combining GSH depletion, proteasome inhibition
and carbonyl scavenging demonstrated a direct link
between protein damage in the form of carbonyls and loss
of cell viability. To the best of our knowledge, this is the
first study to place direct (oxidative) protein carbonylation
within the apoptotic pathway.
MATERIAL AND METHODS
Neuronal cultures and drug treatments
Rat adrenal medullary pheochromocytoma (PC12) cells were
cultured on poly-L-lysine-coated 6-well plates (BioCoat
TM;B D
Biosciences) in RPMI 1640 media containing 10% serum
(7.5% donor horse and 2.5% fetal calf serum; Sigma) and an
antibiotic/antimycotic mixture (Invitrogen). Cells grown at
60–70% confluence were differentiated into a neuronal
phenotype by incubation with 100 ng/ml of NGF (Sigma) for
either 1 or 7 days. Primary neuronal cultures were established
from cerebral cortices of C57BL/6 mice and grown for 7 days
as described by Harms et al. (2010). Housing and handling of
the animals as well as the euthanasia procedure were in strict
accordance with the NIH Guide for the Care and Use of
Laboratory Animals, and were approved by the Institutional
Animal Care and Use Committee. Cells were treated with the
GSH depletor DEM (diethyl maleate; Sigma) for 1–24 h.
Control cells were left untreated after incubation with NGF.
In some cases, DEM-treated cells were incubated with the
proteasome inhibitors lactacystin (Enzo Life Sciences) and
EPO (epoxomicin; Enzo Life Sciences) in the absence or
presence of various compounds including trolox (Sigma), hy-
dralazine (Sigma), methoxylamine (Sigma), z-histidine hydra-
zide (Peninsula Laboratories). Other drugs tested were the
MPTP (mitochondrial permeability transition pore) inhibitor
cyclosporin A (Calbiochem), the pan-caspase inhibitor zVAD-
fmk (benzyloxycarbonyl-Val-Ala-DL-Asp-fluoromethylketone;
Sigma), the apoptosis initiator staurosporine (Sigma) and the
GSH depletor BSO (buthionine sulfoximine; Sigma). After
incubation, cells were homogenized in PEN buffer (20 mM
sodium phosphate, pH 7.5, 1 mM EDTA and 0.1 mM
neocuproine) containing 2 mM 4,5-dihydroxy-1,3-benzene-
disulfonic acid and 1 mM DTT (dithiothreitol). For GSH
determination, cells were homogenized in PEN buffer without
reducing agents and were processed immediately as described
below. Protein homogenates were stored at 280˚C until use.
Protein concentration was assessed with the Bio-Rad DC
TM
protein assay (Bio-Rad Laboratories) using BSA as standard.
Determination of GSH and lipid-peroxidation
products
GSH levels were determined using the enzymatic recycling
method (Shaik and Mehvar, 2006). Briefly, proteins from cell
homogenates were precipitated with 1% sulfosalicylic acid
and removed by centrifugation at 10000 g for 15 min. Ali-
quots of the supernatant were then incubated with 0.4 unit/
ml glutathione reductase, 0.2 mM NADPH and 0.2 mM 5,59-
dithiobis-(2-nitrobenzoic acid) in 1 ml of 0.2 M sodium phos-
phate buffer, pH 7.5, containing 5 mM EDTA. The rate of
appearance of the thionitrobenzoate anion was measured
spectrophotometrically at 412 nm. [GSH] was calculated by
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concentrations of GSSG (0.1–10 nmol).
Lipid peroxidation was estimated as the amount of TBARS
(thiobarbituric acid-reactive substances; Ohkawa et al., 1979).
Briefly, aliquots from the cell homogenates were suspended
in 10% (w/v) trichloroacetic acid containing 1% (w/v)
thiobarbituric and 0.05% (w/v) butylated hydroxytoluene.
Samples were incubated for 20 min at 90˚C. Aggregated
material was removed by centrifugation at 10000 g for
15 min and the absorbance of the supernatant was measured
at 532 nm. The amount of TBARS was calculated using a
standard curve prepared with 1,1,3,3-tetraethoxypropane.
Proteasome activity
The chymotrypsin-like activity of the 20S proteasome was
determined in the cell homogenates using a fluorescence
assay (Rodgers and Dean, 2003). Briefly, 50 mg protein was
incubated for 2 h at 25˚C with 50 mM AMC (7-amino-4-
methylcoumarin)-labelled peptide Suc-Leu-Leu-Val-Tyr-AMC
(Enzo Life Sciences) in the absence or presence of 10 mM b-
clasto-lactacystin-lactone (Enzo Life Sciences). The protea-
some activity was calculated as the difference in fluorescence
intensity at 460 nm between the samples without and with
inhibitor using lex of 380 nm.
Calpain activity
Calpain activity was also determined with a fluorescence
assay using the substrate Suc-Leu-Leu-Val-Tyr-AMC. In this
case, incubation was carried out in 25 mM Hepes buffer, pH
7.5, containing 100 mM KCl and 10 mM CaCl2, in the absence
or presence of 10 mg of calpeptin (Hassen et al., 2006).
Western blot and oxyblot
Proteins (5 mg) were separated by SDS/PAGE on 10% gels and
blotted on to PVDF membranes. Blots then were incubated
overnight at 4˚C with mAb (monoclonal antibody) or poly-
clonal Ab (antibody) against spectrin (mAb, 1:2000; Sigma),
GAP-43 (growth-associated protein 43) (Ab, 1:2000, a gift
from Dr Perrone-Bizzozero, Department of Neurosciences,
School of Medicine, University of New Mexico, Albuquerque,
NM, U.S.A.), c-enolase (Ab, 1:2000; Sigma), active caspase 3
(mAb, 1:1000; Cell Signaling),20Sproteasome a-subunit(mAb,
1:2000; Enzo), 4-HNE (4-hydroxynonenal) (Ab, 1:1000;
Abcam), MDA (malondialdehyde) (Ab, 1:1000; Abcam) and
ACR (acrolein) (Ab, 1:1000; Abcam). Membranes were rinsed
three times in PBS containing 0.05% Tween-20, and then
incubated for 2 h with the appropriate HRP (horseradish
peroxidase)-conjugated secondary Ab. Blots were developed by
enhanced chemiluminescence using the Western Lightning
ECL
TM kit from Perkin-Elmer.
PCO groups were measured by oxyblot analysis as described
earlier (Smerjac and Bizzozero, 2008). In brief, proteins (5 mg)
were incubated with DNPH (2,4-dinitrophenylhydrazine) to
form the DNP (2,4-dinitrophenyl) hydrazone derivatives.
Proteins were separated by electrophoresis and blotted on
to membranes as above. DNP-containing proteins were
detected using rabbit anti-DNP antiserum (1:5000) and
HRP-conjugated goat anti-rabbit IgG Ab (1:2000).
Developed films were scanned in a Hewlett Packard Scanjet
4890 and the images were quantified using the NIH Image
1.63 imaging analysis program. The intensity of each lane on
the film was normalized by the amount of Coomassie Blue
staining in the corresponding lane.
Immunocytochemistry
Cells, cultured on 12 mm round poly-lysine coated coverslips
(BD BioCoat
TM), were fixed with 4% (w/v) paraformaldehyde
for 20 min. For carbonyl staining, fixed cells were incubated
for 15 min with 1 mg/ml DNPH prepared in 1 M HCl to
convert carbonyl groups into DNP-hydrazones. Cells were
rinsed with PBS, blocked with 10% (v/v) normal goat serum
and incubated overnight with rabbit anti-DNP Ab (1:1000;
Sigma). After removing the primary Ab with 0.1% Triton X-
100 in PBS, slides were incubated for 3 h with Alexa FluorH
647 goat anti-rabbit Ab (1:100, Molecular Probes). Cells were
rinsed twice with 0.1% Triton X-100 in PBS. For double
immunofluorescence staining using Click-iTH TUNEL (terminal
deoxynucleotidyltransferase-mediated dUTP nick-end label-
ling) Assay kit (Invitrogen), DNPH-treated specimens were
incubated with terminal deoxynucleotidyl transferase and
dNTPs conjugated to Alexa FluorH 488 azide, rinsed twice
with 0.1% Triton X-100 in PBS, once with PBS, and then
mounted using DPX (di-N-butylphthalate in xylene). Images
were captured with a Zeiss 200 m microscope (Carl Zeiss
MicroImaging Inc.) equipped with a Hamamatsu C4742-95
digital camera (Hamamatsu Corp.). Necrotic cells were
identified on the basis of morphological features such as
swollen cell bodies with many holes, while apoptotic cells
were identified by DNA fragmentation.
For NFH (neurofilament heavy chain) staining, fixed cells
were incubated overnight with mouse anti-NFH Ab (mAb,
1:250; Sigma) followed by a 3 h incubation with Alexa FluorH
488 rabbit anti-mouse Ab (Ab, 1:100; Molecular Probes).
Cell viability assays
ForTrypanBlueexclusionassay,floatingandadherentcellswere
diluted in PBS, stained with 0.4% Trypan Blue for 5 min, and
counted in a Nebauer hemocytometer (Altman et al., 1993). Cell
death was also determined by measuring LDH (lactate
dehydrogenase) activity on a 10 ml aliquot from the cell
supernatant using the LDH-cytotoxicity assay kit II (Abcam).
Protein aggregation assay
Assessment of protein aggregation was carried out as
described by Maisonneuve et al. (2008) with minor modifica-
tions. Cell homogenates prepared in PEN buffer containing
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1631 mM DTT and 150 mM NaCl were centrifuged at 20000 g
for 30 min at 4˚C. The pellets were then extracted with the
same buffer containing 1% Triton X-100. Samples were kept
on ice for 15 min and were centrifuged at 20000 g for
30 min at 4˚C. The final pellet, which contains some
cytoskeleton structures but mostly aggregated proteins, was
re-suspended in PEN buffer for protein determination.
Statistical analysis
Results were analysed for statistical significance with
Student’s t test using GraphPad PrismH program (GraphPad
Software Incorporation).
RESULTS
A low dose of DEM causes partial and transient
GSH depletion in neuronal cells
PC12 cells were differentiated into a neuronal phenotype by
incubation with NGF for 24 h. These cells, which we termed
nPC12 (neuron-like PC12), developed neurites that stained
positive for NFH chain (Figure 1a) and expressed the neuron-
specific markers a-spectrin, GAP-43 and c-enolase (Figure 1b).
Reduction of intracellular GSH levels was attained with DEM.
This membrane-permeable electrophilic agent depletes intra-
cellular GSH by directly conjugating with GSH through GST
(glutathione transferase; formerly known as glutathione S-
transferase; Buchmu ¨ller-Rouiller et al., 1995), leading to
mitochondrial ROS production and oxidative stress (Bizzozero
et al., 2006). As shown in Figure 2(a), DEM dose-dependently
reduced the concentration of GSH in nPC12 cells. For this
study, we chose a concentration of 50 mM DEM to achieve a
reduction in GSH levels similar to that observed in the spinal
cord of EAE mice (Dasgupta and Bizzozero, 2011). At 50 mM
DEM, GSH levels decreased progressively, reaching the lowest
values between 3 and 12 h of incubation. By 24 h, the
concentration of GSH was back to normal (Figure 2b). Since
the thioether linkage between GSH and DEM is metabolically
stable, the recovery of GSH levels at longer incubation times is
likely due to de novo synthesis of the tripeptide. Similar results
were obtained in more differentiated cells such as PC12 cells
treated with NGF for 7 days (Figure 2c) and primary cortical
neurons (Figure 2d).
Protein carbonylation and GSH depletion are
correlated in DEM-treated nPC12 cells
Lipid peroxidation and protein oxidation were evaluated by
measuring TBARS and PCO levels respectively. As shown in
Figure 3(a), TBARS levels do not change during the
incubation of nPC12 cells with 50 mM DEM, although
the mean values were higher at the peak of oxidative stress
(3–12 h). In contrast, the amount of PCOs increased
progressively from 2 to 12 h and then diminished signifi-
cantly by 24 h of incubation (Figure 3b). Again, similar results
were obtained in PC12 cells treated with NGF for 7 days and
in primary cortical neurons (data not shown).
PCOs are not eliminated by enzymatic reduction to the
corresponding alcohols (Bizzozero, 2009). Instead, they are
removed by degradation via the chymotrypsin-like activity of
20S proteasome (Ferrington et al., 2005). We found that this
activity, measured with a fluorogenic peptide substrate, in-
creases 3–4-fold at 3–12 h of incubation to decline thereafter
(Figure 3c). Interestingly, the amount of 20S proteasome, as
determined by the levels of the constitutive a-subunits, follows
the same temporal pattern as that of proteasome activity
(Figure 3c, inset). This suggests that oxidative stress causes up-
regulation in proteasome expression most likely to remove the
potentially toxic misfolded and oxidized proteins that build up
in cells.
DEM treatment leads to apoptosis and necrosis
of nPC12 cells
We next investigated if partial GSH depletion is toxic to
nPC12 cells. As shown in Figure 4, the viability of DEM-
treated nPC12 cells, as determined by the Trypan Blue
exclusion test (Figure 4a) and the LDH cytotoxicity assay
(Figure 4b), gradually decreases up to 12 h of incubation and
by 24 h the proportion of dead cells decreases significantly.
Similar temporal patterns of cell death were obtained for
detached and adherent cell populations (data not shown),
suggesting that dying cells do not automatically detach from
the poly-lysine coated plates. Increased calpain activity, a
marker of both apoptosis and necrosis (Guyton et al., 2005;
Gao et al., 2007), is observed between 3 and 12 h and declines
thereafter (Figure 4c). The increase in calpain activity is also
evident from the reduction in the amount of NFH, one of its
proteolytic targets, (Figure 4d) and from the retraction of
Figure 1 PC12 cells are differentiated into neuron-like cells upon
treatment with NGF
PC12 cells were incubated in the absence or presence of NGF for 24 h as
described in Materials and methods section. (a) Representative immuno-
fluorescence picture of untreated and NGF-treated cells. Nuclear [49,6-
diamidino-2-phenylindole (DAPI)] and NFH staining are shown in blue and
green respectively. Note that, 12 h after NGF treatment, cells are no longer
round and flat but show NFH-positive processes that are characteristic of
neurons. (b) Western blots depicting the expression of the neuron-specific
markers a-spectrin, GAP-43 and c-enolase only in NGF-treated PC12 cells.
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of apoptosis (Namura et al., 1998), was measured by Western
blotting using an Ab that detects the p17 subunit of this
enzyme but not the full-length 32 kDa procaspase 3. As
shown in Figure 4(e), active caspase 3 levels follow a
temporal pattern identical with that of the other two cell-
death markers, suggesting that apoptosis accounts for at
least a fraction of the dead cells. Indeed, morphological
analysis revealed that approximately half of the dead cells
contain the extensive nuclear fragmentation typical of
apoptotic cells (Figure 4f). There is, however, an equal
amount of cells with swollen cytoplasm and intracellular
vacuoles that are characteristic of necrosis.
Temporal/spatial correlation between protein
carbonylation and apoptosis in GSH depleted
nPC12 cells
Since protein carbonylation and cell death shows a similar
temporal pattern, we sought to investigate if there is a spatial
relationship between these two parameters as well. To this
end, DEM-treated cells were double stained with DNPH for
PCOs and TUNEL or annexin V for apoptosis. Consistent with
the results from oxyblot analysis (Figure 3), the average DNP
staining intensity per cell reaches a maximum between 3 and
12 h after addition of DEM and declines thereafter
(Figures 5a and 5b). As shown in Figure 5(c), apoptotic
(TUNEL positive) cells stained intensely with DNPH. Since
DNPH also stained the nuclei, likely due to its reactivity
towards DNA oligonucleotides (Luo and Wehr, 2009), we
quantified the fluorescence in the cytoplasm. As depicted in
Figure 5(d), the fluorescence intensity in the cytoplasm of
apoptotic cells is approximately four times higher than that
of non-apoptotic cells. While there is a significant variation in
DNP staining among the cells, it is clear that the proportion
of cells with the highest cytoplasmic carbonyl content is
elevated between 3 and 12 h (Figure 5e). The temporal/
spatial positive relationship between apoptosis and protein
oxidation was further demonstrated by extensive co-
localization annexin V, a late marker of apoptosis, and DNP
immunoreactivity (Figure 6).
Impaired removal of PCOs increases DEM-
induced cell death
To determine whether accumulation of oxidized/misfolded
proteins plays a role in cell death, we incubated DEM-treated
cells with the proteasome inhibitors EPO and lactacystin.
At a concentration of 1 mM, these drugs were found to
reduce the chymotrypsin-like activity of the 20S protea-
some by 90.6¡13.7% (lactacystin) and 98.9¡7.2% (EPO).
Proteasome inhibitors were added to nPC12 cells 12 h after
addition of DEM and incubation continued until 24 h. As
depicted in Figure 7(a), cells incubated with the inhibitors
Figure 2 DEM induces GSH depletion in nPC12 cells and primary neurons
(a) Effect of various concentrations of DEM on GSH levels in nPC12 cells at 15 min of incubation. (b–d) Time course of GSH depletion
after addition of 50 mM DEM to PC12 cells differentiated for 1 or 7 days (d) with NGF and to primary neurons. Values represent the
means¡S.E.M of 4–9 experiments. Asterisks denote values that are significantly different from those obtained in untreated (UT)
cells; *P,0.05, **P,0.01, ***P,0.001.
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165have significantly higher PCO levels, indicating that in this
system proteasomes are largely responsible for the degrada-
tion of most oxidized proteins. Levels of GSH in the EPO- and
lactacystin-treated cells at 24 h of incubation are similar to
that in untreated cells (Figure 7b). Under these conditions, we
found a large increase in cell death as measured by LDH
release (Figure 7c) and Trypan Blue exclusion assay
(Figure 7d). A correlation between protein carbonylation
Figure 4 Partial GSH depletion leads to apoptosis and necrosis of nPC12 cells
Cells were incubated with 50 mM DEM for various periods of time as described in the Materials and methods section. (a) Cell death
quantified using the Trypan Blue exclusion assay and (b) LDH release. (c) Temporal pattern of calpain activity, a marker of apoptosis
and necrosis. (d) NFH immunostaining intensity. (e) Levels of active caspase 3 were determined by Western-blot analysis (inset). (f)
Quantification of apoptotic and necrotic cell death after 12 h of DEM treatment using morphological analysis. Values represent the
means¡S.E.M. of four experiments. Asterisks denote values that are significantly different from those obtained in untreated (UT)
cells; *P,0.05, **P,0.01, ***P,0.001.
Figure 3 Protein carbonylation and proteasome expression in nPC12 cells increase upon GSH depletion
(a) Levels of TBARS during the course of DEM-induced GSH depletion. (b) Representative oxyblot of total cell proteins during the
course of DEM-induced GSH depletion (upper panel). Lane intensities were measured by scanning densitometry and were used to
calculate protein carbonyl levels as described in the Materials and methods section (lower panel). (c) Proteasome chymotrypsin-like
activity and proteasome a-subunit expression (inset) in DEM-treated nPC12 cells. Values represent the means¡S.E.M. of four
experiments. Asterisks denote values that are significantly different from those obtained in untreated (UT) cells; *P,0.05, **P,0.01,
***P,0.001.
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staining of proteasome inhibited DEM-treated cells
(Figure 7e). These results further support our hypothesis of
a strong relationship between protein damage and neuronal
apoptosis. It is noteworthy that, in the absence of DEM, EPO
and lactacystin do not cause cell death, suggesting that
toxicity of the drug is probably due to its ability to inhibit the
removal of oxidized proteins.
Carbonyl scavengers reduce cell death and
protein aggregation in EPO-treated GSH-
depleted cells
The role of protein carbonylation in cell death was further
explored using the classical RCS (reactive carbonyl species)
scavengers hydralazine, z-histidine hydrazide and methoxyl-
amine. These compounds form Schiff bases with the carbonyl
groups and, with the exception of hydralazine, they have no
antioxidant properties (Zheng and Bizzozero, 2010a). In this
series of experiments, the RCS scavengers were added
together with EPO to cells that had been treated with DEM
for 12 h and incubation continued for another 12 h. As
shown in Figure 8, all three drugs reduced protein carbonyla-
tion, protein aggregation and cell death, indicating that (i)
PCOs are indeed cytotoxic and (ii) protein aggregation is
induced, directly or indirectly, by carbonylation. Preliminary
Western blotting studies revealed that MDA-, ACR- and 4-
HNE-protein adducts are not formed to any appreciable
degree during incubation with DEM, suggesting that
carbonylation takes place by direct oxidation of amino acid
side chain residues rather than by attachment of RCS to the
protein backbone (data not shown). The effectiveness of
the vitamin E analogue trolox at preventing protein
carbonylation and cell death, even when added 12 h after
DEM, suggests that there is still significant oxidative stress
during the recovery phase (Figure 8).
Differential effects of cyclosporin A and zVAD-
fmk on cell death and protein carbonylation
Finally, attempts were made to localize the site of protein
oxidation within the apoptotic pathway. To this end, nPC12
cells were incubated with DEM and either the MPTP inhibitor
cyclosporin A or the pan-caspase inhibitor zVAD-fmk. As
shown in Figure 9, addition of 5 mM cyclosporin A prevents
cell death, protein carbonylation and protein aggregation
induced by GSH depletion. In contrast, pan-caspase inhibition
reduces cell death but has no effect on protein carbonylation
or aggregation (Figure 10). These findings suggest that
protein oxidation/aggregation occurs after MPTP opening
but before caspase activation.
DISCUSSION
In the present study, we show that a moderate and transient
depletion of GSH in nPC12 cells leads to increased
Figure 5 Temporal and spatial correlation between carbonylation and apoptosis in DEM-treated nPC12 cells
(a) Immunocytochemical detection of carbonyls in DEM-treated nPC12 cells at different time points. Carbonyls were detected with
anti-DNP antibodies after derivatization with DNPH (red). TUNEL staining for apoptosis and 49,6-diamidino-2-phenylindole (DAPI)
staining for nuclei are shown in green and blue respectively. (b) Total carbonyl content of DEM-treated nPC12 cells determined by
immunocytochemistry. Asterisks denote values that are significantly different from those obtained in untreated (UT) cells; *P,0.05,
***P,0.001. (c) Anti-DNP staining in the nucleus and cytoplasm of TUNEL positive cells. (d) PCO levels in the cytoplasm of TUNEL
positive cells (TPC) and TUNEL negative cells (TNC) at 12 h of treatment with DEM. *P,0.05. (e) Average fluorescence intensity (Fl) in
the cytoplasm of nPC12 cells increases between 3 and 12 h of incubation with DEM. Values represent the means¡S.E.M. of 100–200
cells per experiment.
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167accumulation of PCOs and cell death. Both the amount of
PCOs and the proportion of dead cells diminish as GSH is
biosynthetically replenished. However, cell death persists if
oxidized proteins are not removed by the proteasome. These
results suggest that the build-up of oxidized and/or misfolded
proteins is responsible for the loss of cell viability in this
system. Furthermore, the effectiveness of several RCS
scavengers at preventing cell death suggests that PCOs are
indeed the toxic species. Experiments using cyclosporin A and
zVAD-fmk place protein carbonylation downstream of the
MPTP opening and upstream of caspase activation. While
the study focused on nPC12 cells, experiments using more
differentiated PC12 cells and primary neuronal cultures
yielded the same results, indicating that the above findings
are not circumscribed to partially differentiated dopaminer-
gic neurons. A schematic model summarizing our experi-
mental findings is shown in Figure 11.
DEM is commonly used to deplete both cytoplasmic and
mitochondrial GSH and to cause oxidative stress and cell
death (Freeman and Meredith, 1988). At millimolar concen-
trations, DEM is highly toxic and causes cell death mostly by
necrosis (Nagai et al., 2002). Our study employed a much
lower concentration (i.e. 50 mM) of DEM to achieve the
partial GSH depletion detected in the spinal cord of EAE mice,
where there is significant neuronal apoptosis (Dasgupta and
Bizzozero, 2011). Under these conditions, ,50% of the dead
cells measured after 12 h of incubation with DEM displayed
morphological features that are characteristic of apoptosis,
with the rest being necrotic cells. A switch from apoptosis to
necrosis in models with severe oxidative stress has been
attributed to reduction in ATP levels below a threshold that is
insufficient to support apoptosis, an energy-depended
process (Eguchi et al., 1997). The mechanism linking GSH
depletion and increased production of ROS by mitochondria
has been studied extensively (Armstrong and Jones, 2002;
Shen et al., 2005). It is generally accepted that a decline in
the GSH/GSSG ratio leads to the opening of the MPTP by
oxidation of a critical dithiol in the voltage-sensing region of
this protein complex (Petronilli et al., 1994). When GSH falls
below a certain level, permeability transition occurs, followed
by a collapse in mitochondrial membrane potential. This event
causes enhanced production of superoxide either from the
rise in redox cycling of ubiquinone within Complex III (Chen
et al., 2003) or from the reverse electron transport from
Figure 6 Annexin V-positive cells have high carbonyl content
(a) Co-localization of carbonyls and annexin V in nPC12 cells during GSH depletion. Carbonyls were detected with anti-DNP
antibodies after derivatization with DNPH (red). Annexin V staining for apoptosis and 49,6-diamidino-2-phenylindole (DAPI) staining
for nuclei are shown in green and blue respectively. (b) DAPI staining was subtracted from the picture corresponding to 12 h
incubation with DEM to better show the co-localization of carbonyls and annexin V. (c) Carbonyl intensity in annexin V-positive cells
(AVPC) and annexin V-negative cells (AVNC) at 12 h of treatment with DEM. Values represent the means¡S.E.M. of 200 cells per
experiment; *P,0.05.
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and apoptosis of DEM-treated nPC12 cells
Cells were incubated with or without 50 mM DEM for 12 h, after which 1 mM
EPO (DE12, E12) or 1 mM lactacystin (L12, DL12) was added to the medium
and incubation continued for another 12 h. D24 corresponds to cells
incubated with DEM for the entire 24 h period. (a) PCO levels determined by
oxyblot. (b) Glutathione assayed by spectrophotometric analysis. (c, d) Cell
death quantified using the Trypan Blue exclusion assay and LDH release. (e)
PCO levels in the cytoplasm of TUNEL-positive cells (TPC) and TUNEL-negative
cells (TNC) in DEM-treated cells incubated for 12 h with epoxomixin (DE12)
or lactacystin (DL12). Values represent the means¡S.E.M. of four experi-
ments. Asterisks denote values that are significantly different from D24;
*P,0.05, **P,0.01, ***P,0.001.
Figure 8 Addition of carbonyl scavengers to DEM/EPO-treated nPC12
cells prevents protein aggregation and cell death
Cells were incubated with or without 50 mM DEM for 12 h, after which EPO
(1 mM) along with various scavengers (500 mM) were added to the medium
and incubation continued for another 12 h. (a) Glutathione levels assayed by
spectrophotometric analysis. (b) PCO levels determined by oxyblot. (c) Protein
aggregation measured by differential centrifugation. (d) Cell death quantified
using the Trypan Blue exclusion assay. Values represent the means¡S.E.M. of
four experiments. Asterisks denote values that are significantly different
(**P,0.01, ***P,0.001) from untreated cells. Hash symbols denote values
that are significantly different (
#P,0.05,
##P,0.01,
###P,0.001) from
DEM/EPO-treated cells.
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169succinate to NADH within Complex I (Lambert and Brand,
2004). Loss of cytochrome c from mitochondria, after
permeability transition and swelling, can also augment the
production of oxygen-free radicals by reducing the redox
centres upstream of Complex IV (Votyakova and Reynolds,
2005). Our data are in agreement with this model since MPTP
inhibition with cyclosporin A reduces protein oxidation and
cell death (both apoptosis and necrosis). They also indicate
that carbonylation occurs after MPTP opening and as the
result of the ensuing high degree of oxidative stress. It should
be emphasized that our findings are not restricted to DEM-
induced cell death as a similar relationship between car-
bonylation and apoptosis was established in staurosporine-
and BSO-treated nPC12 cells (Supplementary Figures S1 and
S2 available at http://www.asnneuro.org/an/004/an004e084add.htm).
It is also interesting that, by 24 h of incubation, the surviving cells
a r ea b l et or e p l e n i s ht h eG S Hp o o lc o m p l e t e l y .R e c o v e r yo fG S H
levelshasalsobeenobservedinthe brain ofrats treated with DEM
(Gupta et al., 2000) and in cultured astrocytes incubated with the
DEM-analogue dimethyl fumarate (Lin et al., 2011), and it is
generally ascribed to an antioxidant response that increases the
amount of c-glutamylcysteine synthetase, the rate-limiting
enzyme of GSH biosynthesis (Lewerenz and Maher, 2011).
The incorporation of aldehyde and ketone functional
groups into proteins takes place by direct and indirect
mechanisms (Bizzozero, 2009). Direct protein carbonylation
involves the metal ion-catalysed oxidation of threonine,
lysine, arginine and proline residues to a-amino-b-oxobutyric
acid, a-aminoadipic semialdehyde and glutamic semialdehyde
respectively. In contrast, indirect carbonylation entails the
reaction of the nucleophilic centres in cysteine, histidine or
lysine residues with RCS, bifunctional carbonyl-containing
molecules derived from the oxidation of lipids (e.g. 4-HNE,
MDA and ACR) and carbohydrates (e.g. glyoxal and
methylglyoxal) (Bizzozero, 2009). Our finding that the RCS
scavengers hydralazine, methoxylamine and histidine hydra-
zide prevent the formation of PCOs initially suggested that
carbonylation is occurring by an indirect mechanism. How-
ever, we were unable to detect RCS–protein adducts,
implying that direct oxidation of amino acids residues is
the most likely process and that the scavengers are able to
form stable adducts with oxidized proteins. It is noteworthy
that direct carbonylation appears to be also the major
mechanism underlying the formation of carbonyls in the CNS
of EAE mice (Zheng and Bizzozero, 2010b).
Carbonylated proteins in mitochondria and cytoplasm are
digested by the Lon protease (Bota and Davies, 2002) and the
20S proteasome (Grune et al., 1997) respectively. While
lactacystin can inhibit both of these proteolytic systems, EPO
is highly specific for the proteasome (Kisselev and Goldberg,
2001). Thus, our findings suggest that cytoplasmic oxidized
proteins are likely responsible for damage of nPC12 cells
during GSH depletion. The 20S proteasome by itself plays a
critical protective role during oxidative stress by digesting
oxidized proteins via its chymotrypsin-like activity and
without requirement for ubiquitin or energy (Shringarpure
Figure 9 Cyclosporin A prevents protein carbonylation, protein aggregation and cell death (both necrosis and apoptosis) induced by
partial GSH depletion
nPC12 cells were incubated for 12 h with 50 mM DEM in the absence or presence of 5 mM cyclosporin A (CsA), a classical MPTP
inhibitor. (a) The proportion of necrotic and apoptotic cells determined by morphological analysis of 400 cells. (b) GSH levels
measured by spectrophotometric analysis. (c) PCO levels measured by oxyblot. (d) Protein aggregation measured by differential
centrifugation. Values represent the means¡S.E.M. of three experiments. Asterisks denote values that are significantly different
(*P,0.05, **P,0.01, ***P,0.001) from untreated cells. Hash symbols denote values that are significantly different (
#P,0.05,
##P,0.01) from DEM-treated cells.
A. Dasgupta and others
170 E 2012 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/)
which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.et al., 2003). Indeed, we have observed a rapid and large rise
in proteasome expression and activity upon GSH depletion.
This is in agreement with a recent study showing increased
expression of 20S proteasome, immunoproteasome and the
P28a/b regulatory particle upon incubation of murine
embryonic fibroblasts with H2O2, which was interpreted as
an oxidative stress adaptation mechanism designed to reduce
the load of oxidized protein in the cell (Pickering et al., 2010).
In our system, however, the elevation in proteasomal
chymotrypsin-like activity was not sufficient to prevent the
accumulation of PCOs that occurs during first 12 h of incub-
ation with DEM, and addition of epoxomixin or lactacystin
results in a further build-up of oxidized proteins. In-
terestingly, incubation of nPC12 cells with EPO or lactacystin
alone (i.e. in the absence of DEM) does not lead to any
appreciable increase in protein carbonylation, protein ag-
gregation or cell death, indicating that basal protein
oxidation in these neuron-like cells is quite low. In liver
cells, however, proteasome inhibition causes increased
carbonyl formation and protein aggregation, even in the
absence of an obvious oxidative challenge (Demasi and
Davies, 2003). This discrepancy could be attributed to
differences in the cell type, the turnover rate of damaged
proteins and the incubation conditions.
It has been shown that carbonylation causes inappropriate
inter- and intra-protein cross-links as well as protein
misfolding, which in turn results in the formation of high-
molecular-mass aggregates (Grune et al., 1997; Mirzaei and
Regnier, 2008). As these aggregates get larger, they
precipitate, become resistant to proteolytic degradation and
reduce cell viability (Nystro ¨m, 2005; Maisonneuve
et al., 2008). The precise relationship between protein
aggregate formation and apoptosis, or whether the aggre-
gates are themselves cytotoxic, is unclear. However, it has
Figure 10 Pan-caspase inhibition reduces necrosis and apoptosis of nPC12 cells induced by partial GSH depletion without effecting
protein carbonylation or aggregation
nPC12 cells were incubated for 12 h with 50 mM DEM in the absence or presence of 10 mM zVAD-fmk, a classical pan-caspase
inhibitor (PCI). (a) Representative oxyblot of total cell proteins. UT, untreated. Lane intensities were measured by scanning
densitometry and were used to calculate PCO levels (b). (c) Western blot of total cell proteins developed with anti-caspase 3 Ab. (d)
GSH levels measured by spectrophotometric analysis. (e) The proportion of necrotic and apoptotic cells determined by
morphological analysis of 400 cells. (f) Protein aggregation measured by differential centrifugation. Values represent the
means¡S.E.M. of five experiments. Asterisks denote values that are significantly different (*P,0.05, **P,0.01 and ***P,0.001)
from untreated cells. Hash symbols denote values that are significantly different (
#P,0.05 and
##P,0.01) from DEM-treated cells.
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171been recently discovered that protein aggregates, as they
form, sequester multiple pre-existent and newly synthesized
proteins that have essential cellular functions and are critical
for cell survival (Olzscha et al., 2011). Our results show that
various carbonylation scavengers are able to prevent protein
aggregation and cell death, suggesting that during GSH
depletion oxidized proteins are critical for aggregate
formation and cytotoxicity. In our system, protein aggregates
clearly are not made of carbonylated proteins alone, since the
cellular amount of carbonylated proteins is roughly 1–2% of
that of the aggregates. However, protein carbonylation may
expose hydrophobic surfaces that can mediate aberrant
interactions with other (non-oxidized) proteins, resulting in
their functional impairment and sequestration. Future studies
will test whether agents capable of preventing protein
aggregation can also reduce cell death without changing the
extent of protein carbonylation.
Carbonylation of specific proteins has been found to be
toxic as well. For instance, the occurrence of carbonyls in
GAPDH (glyceraldehyde-3-phosphate dehydrogenase), ANT
(adenine nucleotide translocator) and Bcl-2 has been shown
to play a role in nitric oxide-induced apoptosis in insulin-
producing RINm5F cells (Cahuana et al., 2004). Carbonyl
modification of several chaperones, including glucose-
regulated protein-78, heat-shock protein-60, heat-shock
protein cognate-71, protein disulfide isomerase and calreti-
culin, has been linked to apoptosis of irradiated HL60 human
leukaemia cells (Magi et al., 2004). Furthermore, apoptosis of
etopside-treated HL60 cells is caused by reduced rate of gly-
colysis, which likely results from the extensive carbonylation
of several glycolytic enzymes including aldolase, enolase,
triosephosphate isomerase and phosphoglycerate mutase
(England et al., 2004). Characterization of the carbonyl
proteome of PC12 cells will determine whether similar
metabolic pathways or cellular processes are affected during
GSH depletion.
In sum, the present study identifies direct protein
carbonylation as a critical step in neuronal cell death
triggered by GSH depletion. While it is clear that other
cytotoxic mechanisms may be at play in EAE, it is tempting to
speculate that the reduced levels of GSH and the accumula-
tion of PCOs observed in this disease (Dasgupta and
Bizzozero, 2011) play a significant pathophysiological role.
The novel findings presented herein form the basis for
exploring the factors that contribute to the maintenance of
low levels of PCOs within cells but most importantly for
Figure 11 Schematic diagram that incorporates the major findings of this study
Partial GSH depletion increases the production of mitochondrial ROS, which are responsible for the incorporation of carbonyl groups
into proteins. The rise in proteasomal expression and activity that occurs during the first 12 h of incubation is not sufficient to
overcome the increase in protein oxidation (indicated as q[O]/PA or increased oxidation/proteasome activity ratio), leading to the
progressive accumulation of PCOs. Some cells accumulate more PCOs than others, perhaps reflecting variations in antioxidant
defence mechanisms and/or in proteasome expression. When protein oxidation reaches a threshold value (3–12 h of incubation), it
triggers apoptosis/necrosis. As incubation progresses, dead cells are removed from the system and the surviving cells slowly
replenish their GSH to normal levels, leading to a Q[O]/PA ratio, a decline in PCO accumulation and reduced cell death. Addition of
EPO at the beginning of this period prevents the proteasome-mediated removal of damaged proteins causing a build-up of PCOs
and loss of cell viability. These effects are prevented by several RCS scavengers, indicating that protein carbonylation is indeed toxic
to cells.
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death in EAE and potentially MS.
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